Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04838392
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Bionime Corporation
- Registry
-
NCT04838392
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT04838392. Allocation not applicable; no masking; primary purpose treatment. Start 2024-12 (anticipated); primary completion 2025-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
- Condition
- Diabetes Mellitus
- Condition
- Type 1 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Device)
- RIGHTEST Continuous Glucose Monitoring System
- Lead sponsor
- Bionime Corporation
Record details
- Record id
cardio:ct-nct04838392- Content hash
4718f6b7af6211dbec5b1404b41a56305fa77a2d6583a940e44f9fd351a3b377